Tratamiento de la epilepsia por medio de la estimulacion vagal

Translated title of the contribution: Vagal nerve stimulation in the treatment of epilepsy

L. A. Alvarez, P. Dean, P. Jayakar, M. Duchowny, T. Resnick, C. Dunoyer, S. Koh

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction. Vagal nerve stimulation is the latest therapeutic modality for the treatment of epilepsy. It consists of a lead implanted in the left vagal nerve which is connected to a subcutaneous stimulator implanted in the left axillary or pectorial region. Development. The stimulator is programmed to intermittently stimulate the vagal nerve throughout the day and a magnet also allows the patient to control the stimulation from the outside. This treatment has been used in patients with intractable partial seizures who are not candidates for epilepsy surgery. The results reported have varied but in general the procedure appears promising with at least 50% of the implanted having over 50% improvement in their seizure frequency and many having complete control without significant side effects. Conclusion. Further review of the results are still needed to fully determine the true value of this treatment and to identify the subgroups of patients which will benefit the most.

Original languageSpanish
Pages (from-to)385-387
Number of pages3
JournalRevista de Neurologia
Volume29
Issue number4
StatePublished - Aug 16 1999

Fingerprint

Vagus Nerve Stimulation
Epilepsy
Seizures
Magnets
Therapeutics

Keywords

  • Epilepsy
  • Seizures
  • Vagal nerve stimulation

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Alvarez, L. A., Dean, P., Jayakar, P., Duchowny, M., Resnick, T., Dunoyer, C., & Koh, S. (1999). Tratamiento de la epilepsia por medio de la estimulacion vagal. Revista de Neurologia, 29(4), 385-387.

Tratamiento de la epilepsia por medio de la estimulacion vagal. / Alvarez, L. A.; Dean, P.; Jayakar, P.; Duchowny, M.; Resnick, T.; Dunoyer, C.; Koh, S.

In: Revista de Neurologia, Vol. 29, No. 4, 16.08.1999, p. 385-387.

Research output: Contribution to journalArticle

Alvarez, LA, Dean, P, Jayakar, P, Duchowny, M, Resnick, T, Dunoyer, C & Koh, S 1999, 'Tratamiento de la epilepsia por medio de la estimulacion vagal', Revista de Neurologia, vol. 29, no. 4, pp. 385-387.
Alvarez LA, Dean P, Jayakar P, Duchowny M, Resnick T, Dunoyer C et al. Tratamiento de la epilepsia por medio de la estimulacion vagal. Revista de Neurologia. 1999 Aug 16;29(4):385-387.
Alvarez, L. A. ; Dean, P. ; Jayakar, P. ; Duchowny, M. ; Resnick, T. ; Dunoyer, C. ; Koh, S. / Tratamiento de la epilepsia por medio de la estimulacion vagal. In: Revista de Neurologia. 1999 ; Vol. 29, No. 4. pp. 385-387.
@article{003d17772cbe4506ae4e3247f24aed0c,
title = "Tratamiento de la epilepsia por medio de la estimulacion vagal",
abstract = "Introduction. Vagal nerve stimulation is the latest therapeutic modality for the treatment of epilepsy. It consists of a lead implanted in the left vagal nerve which is connected to a subcutaneous stimulator implanted in the left axillary or pectorial region. Development. The stimulator is programmed to intermittently stimulate the vagal nerve throughout the day and a magnet also allows the patient to control the stimulation from the outside. This treatment has been used in patients with intractable partial seizures who are not candidates for epilepsy surgery. The results reported have varied but in general the procedure appears promising with at least 50{\%} of the implanted having over 50{\%} improvement in their seizure frequency and many having complete control without significant side effects. Conclusion. Further review of the results are still needed to fully determine the true value of this treatment and to identify the subgroups of patients which will benefit the most.",
keywords = "Epilepsy, Seizures, Vagal nerve stimulation",
author = "Alvarez, {L. A.} and P. Dean and P. Jayakar and M. Duchowny and T. Resnick and C. Dunoyer and S. Koh",
year = "1999",
month = "8",
day = "16",
language = "Spanish",
volume = "29",
pages = "385--387",
journal = "Revista de Neurologia",
issn = "0210-0010",
publisher = "Revista de Neurologia",
number = "4",

}

TY - JOUR

T1 - Tratamiento de la epilepsia por medio de la estimulacion vagal

AU - Alvarez, L. A.

AU - Dean, P.

AU - Jayakar, P.

AU - Duchowny, M.

AU - Resnick, T.

AU - Dunoyer, C.

AU - Koh, S.

PY - 1999/8/16

Y1 - 1999/8/16

N2 - Introduction. Vagal nerve stimulation is the latest therapeutic modality for the treatment of epilepsy. It consists of a lead implanted in the left vagal nerve which is connected to a subcutaneous stimulator implanted in the left axillary or pectorial region. Development. The stimulator is programmed to intermittently stimulate the vagal nerve throughout the day and a magnet also allows the patient to control the stimulation from the outside. This treatment has been used in patients with intractable partial seizures who are not candidates for epilepsy surgery. The results reported have varied but in general the procedure appears promising with at least 50% of the implanted having over 50% improvement in their seizure frequency and many having complete control without significant side effects. Conclusion. Further review of the results are still needed to fully determine the true value of this treatment and to identify the subgroups of patients which will benefit the most.

AB - Introduction. Vagal nerve stimulation is the latest therapeutic modality for the treatment of epilepsy. It consists of a lead implanted in the left vagal nerve which is connected to a subcutaneous stimulator implanted in the left axillary or pectorial region. Development. The stimulator is programmed to intermittently stimulate the vagal nerve throughout the day and a magnet also allows the patient to control the stimulation from the outside. This treatment has been used in patients with intractable partial seizures who are not candidates for epilepsy surgery. The results reported have varied but in general the procedure appears promising with at least 50% of the implanted having over 50% improvement in their seizure frequency and many having complete control without significant side effects. Conclusion. Further review of the results are still needed to fully determine the true value of this treatment and to identify the subgroups of patients which will benefit the most.

KW - Epilepsy

KW - Seizures

KW - Vagal nerve stimulation

UR - http://www.scopus.com/inward/record.url?scp=0033575557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033575557&partnerID=8YFLogxK

M3 - Article

C2 - 10797931

AN - SCOPUS:0033575557

VL - 29

SP - 385

EP - 387

JO - Revista de Neurologia

JF - Revista de Neurologia

SN - 0210-0010

IS - 4

ER -